Adirna Therapeutics is a biotechnology company that harnesses the power of artificial intelligence and big data to advance RNA-based precision medicine. Our focus is on the dark genome, the vast and largely unexplored regions of the genome that encode regulatory non-coding RNAs (ncRNAs). We use our proprietary database and AI-powered technology platforms to find and validate novel targets and associated biomarkers effectively and efficiently, and develop precision therapeutics for diseases with high unmet medical needs via an extensive partnership model.
Company Details
- Founded
- 2023
- Address
- 100 Walnut Ave., Clark,nj 07066,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://adirnatx.com/
- Keywords
- artificial intelligence, bioinformatics, genomics, big data, RNA therapeutics, precision medicine, dark genome, ncRNAs, diagnostics, neoantigen, subpopulation analysis, drug rescue.
- HQ
- Clark, NJ
Adirna Therapeutics, Inc. Questions
Adirna Therapeutics, Inc.'s website is https://adirnatx.com/
Adirna Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/adirnatx
Adirna Therapeutics, Inc.'s industry is
Biotechnology Research
Adirna Therapeutics, Inc.'s top competitors are
Skingenie,
Admera Health,
Proto.life,
Score Pharma, Inc.,
Westfield Bioventures,
Omega Bioservices,
Ribogenics, Inc.,
Obcure Therapeutics, Inc.,
Cello Therapeutics, Inc.,
Ptc Therapeutics, Inc..
Adirna Therapeutics, Inc.'s categories are Biotechnology Research
Adirna Therapeutics, Inc.'s founding year is 2023
